Theranostic pretargeted radioimmunotherapy of internalizing solid tumor antigens in human tumor xenografts in mice: Curative treatment of HER2-positive breast carcinoma
Sarah M. Cheal(Memorial Sloan Kettering Cancer Center), Nai‐Kong V. Cheung(Memorial Sloan Kettering Cancer Center)
Cited by 39
Related Papers
GD2 or HER2 targeting T cell engaging bispecific antibodies to treat osteosarcoma
|Journal of Hematology & Oncology|2020|86
Potent ex vivo armed T cells using recombinant bispecific antibodies for adoptive immunotherapy with reduced cytokine release
|Journal for ImmunoTherapy of Cancer|2021|47